表紙:ウイメンズヘルス市場:2024-2034年
市場調査レポート
商品コード
1453732

ウイメンズヘルス市場:2024-2034年

Women's Health Market Report 2024-2034

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 351 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=204.74円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ウイメンズヘルス市場:2024-2034年
出版日: 2024年03月18日
発行: Visiongain Reports Ltd.
ページ情報: 英文 351 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のウイメンズヘルスの市場規模は、2034年にかけてCAGR 4.6%で成長すると予測されています。

女性の健康問題に対する意識の高まり:

女性の健康問題に対する意識の高まりにより、ウイメンズヘルス市場は大きな成長を遂げています。この成長の背景には、医療支出の増加、医療技術の進歩、予防医療への関心の高まりなど、さまざまな要因があります。リプロダクティブヘルス、妊産婦の健康、乳房の健康、更年期管理、性の健康など、女性特有の健康ニーズに対応する製品やサービスへの需要が高まっています。さらに、女性の健康教育とアドボカシーを推進するイニシアチブが、女性特有の健康懸念と早期発見・早期治療の重要性に対する理解を深めることに貢献しています。ウイメンズヘルス市場は拡大を続け、世界の女性にイノベーションと健康改善の機会を提供すると予想されています。

患者ケアにおける技術の進歩:

技術の進歩はウイメンズヘルス市場の情勢を急速に変え、イノベーションと患者ケアの改善の新時代を切り開いています。高度な診断ツールから最先端の治療方法まで、これらの進歩は健康状態の診断、管理、治療方法に革命をもたらしています。3DマンモグラフィやMRIなどの高度な画像診断技術は、乳癌を早期段階で発見する精度を高め、生存率を向上させ、侵襲的な処置の必要性を減らしています。腹腔鏡手術やロボット支援手術などの低侵襲手術技術は、子宮内膜症や子宮筋腫などの婦人科疾患に対処するためのより安全で効果的な選択肢を提供しています。さらに、モバイルアプリ、ウェアラブルデバイス、遠隔医療プラットフォームなどのデジタルヘルスソリューションは、情報への便利なアクセス、モニタリングツール、医療提供者との仮想相談を提供することで、女性が自分の健康を管理する力を与えています。これらの技術革新は、女性の健康成果を向上させ、市場成長を促進し、ウイメンズヘルス分野におけるケア全体の質を向上させる上で、大きな可能性を秘めています。

当レポートでは、世界のウイメンズヘルスの市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場推進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 ウイメンズヘルス市場の分析:用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 避妊薬
  • 閉経後骨粗鬆症
  • ホルモン性不妊症
  • 閉経
  • 多嚢胞性卵巣症候群
  • 子宮内膜症・子宮筋腫
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 ウイメンズヘルス市場の分析:流通チャネル別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 病院薬局
  • 小売薬局
  • オンライン薬局
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 ウイメンズヘルス市場の分析:医薬品別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • Xgeva
  • Prolia
  • Mirena
  • Nexplanon
  • Forteo
  • Nuvaring
  • Premarin
  • Lupron
  • Lo Loestrin
  • Orilissa/Oriahnn
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第7章 ウイメンズヘルス市場の分析:タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • ジェネリック薬
  • ブランド薬
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第8章 ウイメンズヘルス市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第9章 北米のウイメンズヘルス市場の分析

第10章 欧州のウイメンズヘルス市場の分析

第11章 アジア太平洋のウイメンズヘルス市場の分析

第12章 ラテンアメリカのウイメンズヘルス市場の分析

第13章 中東・アフリカのウイメンズヘルス市場の分析

第14章 企業プロファイル

  • 競合情勢
  • 戦略的展望:サマリー
  • Abbott Laboratories
  • Bayer AG
  • Caldera Medical Inc.
  • Cardinal Health
  • Carestream Health
  • Cooper Surgical Inc.
  • L. Hoffman-La Roche Ltd.
  • General Electric Healthcare
  • Hologic Inc.
  • koninklijke philips n.v
  • MedGyn Products Inc.
  • Medline Industries, Inc.
  • Prestige Consumer Healthcare Inc.
  • Siemens AG

第15章 総論・提言

  • Visiongainによる総論
  • 参入企業への推奨事項
図表

List of Tables

  • Table 1 Women's Health Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Women's Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Women's Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Women's Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Women's Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 7 Contraceptives Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 8 Postmenopausal Osteoporosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 9 Hormonal Infertility Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 10 Menopause Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 11 Polycystic Ovary Syndrome Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 12 Endometriosis and Uterine Fibroids Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 13 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 14 Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 15 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 16 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 17 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 18 Women's Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Xgeva Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 20 Prolia Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 21 Mirena Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 22 Nexplanon Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 23 Forteo Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 24 Nuvaring Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 25 Premarin Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 26 Lupron Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 27 Lo Loestrin Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 28 Orilissa/Oriahnn Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 30 Women's Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 31 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 32 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 33 Women's Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 34 North America Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 35 North America Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 36 North America Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 37 North America Women's Health Market Drugs, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 38 North America Women's Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 39 U.S. Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 40 Canada Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 41 Europe Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 42 Europe Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 43 Europe Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 44 Europe Women's Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 Europe Women's Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 46 Germany Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 47 France Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 48 UK Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 49 Italy Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 50 Spain Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 51 Russia Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 52 Poland Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 53 Belgium Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 54 Rest of Europe Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 55 Asia Pacific Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 56 Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 57 Asia Pacific Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 58 Asia Pacific Women's Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Asia Pacific Women's Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 60 Japan Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 61 China Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 62 India Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 63 Australia Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 64 South Korea Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 65 Singapore Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 66 Taiwan Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 67 Rest of Asia Pacific Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 68 Latin America Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 69 Latin America Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 70 Latin America Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 71 Latin America Women's Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 Latin America Women's Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 73 Brazil Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 74 Mexico Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 75 Argentina Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 76 Colombia Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 77 Rest of Latin America Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 78 MEA Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 79 MEA Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 80 MEA Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 81 MEA Women's Health Market by Drugs, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 82 MEA Women's Health Market by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 83 GCC Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 84 South Africa Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 85 Rest of MEA Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 86 Strategic Outlook
  • Table 87 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Abbott Laboratories: Product Benchmarking
  • Table 89 Abbott Laboratories: Strategic Outlook
  • Table 90 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Bayer AG: Product Benchmarking
  • Table 92 Bayer AG: Strategic Outlook
  • Table 93 Caldera Medical Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Caldera Medical Inc: Product Benchmarking
  • Table 95 Caldera Medical Inc: Strategic Outlook
  • Table 96 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Cardinal Health: Product Benchmarking
  • Table 98 Cardinal Health: Strategic Outlook
  • Table 99 Carestream health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Carestream Health: Product Benchmarking
  • Table 101 Carestream Health: Strategic Outlook
  • Table 102 Cooper Surgical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Cooper Surgical, Inc.: Product Benchmarking
  • Table 104 Cooper Surgical, Inc.: Strategic Outlook
  • Table 105 L. Hoffman-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 L. Hoffman-La Roche Ltd.: Product Benchmarking
  • Table 107 Debiotech SA: Strategic Outlook
  • Table 108 General Electric Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 General Electric Healthcare: Product Benchmarking
  • Table 110 General Electric Healthcare: Strategic Outlook
  • Table 111 Hologic Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Hologic Inc: Product Benchmarking
  • Table 113 Hologic Inc.: Strategic Outlook
  • Table 114 koninklijke philips n.v: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Koninklijke Philips N.V: Product Benchmarking
  • Table 116 Koninklijke Philips N.V: Strategic Outlook
  • Table 117 MedGyn Products Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 MedGyn Products, Inc.: Product Benchmarking
  • Table 119 Medline Industries, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 Medline Industries Inc: Product Benchmarking
  • Table 121 Prestige Consumer Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 Prestige Consumer Healthcare Inc.: Product Benchmarking
  • Table 123 Siemens AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Siemens AG: Product Benchmarking
  • Table 125 Siemens AG: Strategic Outlook

List of Figures

  • Figure 1 Women's Health Market Segmentation
  • Figure 2 Women's Health Market by Application: Market Attractiveness Index
  • Figure 3 Women's Health Market by Distribution Channel: Market Attractiveness Index
  • Figure 4 Women's Health Market by Drugs: Market Attractiveness Index
  • Figure 5 Women's Health Market by Type: Market Attractiveness Index
  • Figure 6 Women's Health Market Attractiveness Index by Region
  • Figure 7 Women's Health Market: Market Dynamics
  • Figure 8 Women's Health Market by Region, 2024-2034 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 9 Women's Health Market by Region, 2024-2034 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 10 Women's Health Market by Region, 2024-2034 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 11 Women's Health Market by Region, 2024-2034 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 12 Women's Health Market: Porter's Five Forces Analysis
  • Figure 13 Women's Health Market: PEST Analysis
  • Figure 14 Women's Health Market by Application: Market Attractiveness Index
  • Figure 15 Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 16 Women's Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 17 Contraceptives Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 18 Contraceptives Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Postmenopausal Osteoporosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 20 Postmenopausal Osteoporosis Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Hormonal Infertility Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 22 Hormonal Infertility Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Menopause Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 24 Menopause Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 25 Polycystic Ovary Syndrome Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 26 Polycystic Ovary Syndrome Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Endometriosis and Uterine Fibroids Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 28 Endometriosis and Uterine Fibroids Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 30 Others Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 31 Women's Health Market by Distribution Channel: Market Attractiveness Index
  • Figure 32 Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
  • Figure 33 Women's Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 34 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 35 Hospital Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 37 Retail Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 39 Online Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 40 Women's Health Market by Drugs: Market Attractiveness Index
  • Figure 41 Women's Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
  • Figure 42 Women's Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 43 Xgeva Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 44 Xgeva Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Prolia Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 46 Prolia Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Mirena Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 48 Mirena Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 49 Nexplanon Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 50 Nexplanon Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 51 Forteo Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 52 Forteo Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 53 Nuvaring Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 54 Nuvaring Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 55 Premarin Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 56 Premarin Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 57 Lupron Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 58 Lupron Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 59 Lo Loestrin Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 60 Lo Loestrin Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 61 Orilissa/Oriahnn Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 62 Orilissa/Oriahnn Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 63 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 64 Others Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 65 Women's Health Market by Type: Market Attractiveness Index
  • Figure 66 Women's Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 67 Women's Health Market Share Forecast by Type 2024, 2029, 2034 (%)
  • Figure 68 Generic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 69 Generic Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 70 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 71 Branded Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 72 Women's Health Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
  • Figure 73 Women's Health Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 74 Women's Health Market by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 75 North America Women's Health Market Attractiveness Index
  • Figure 76 North America Women's Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 77 North America Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 78 North America Women's Health Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 79 North America Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 80 North America Women's Health Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 81 North America Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 North America Women's Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
  • Figure 83 North America Women's Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 North America Women's Health Market Share Forecast by Drugs, 2024 & 2034 (%)
  • Figure 85 North America Women's Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 86 North America Women's Health Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 87 U.S. Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 88 Canada Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 89 Europe Women's Health Market Attractiveness Index
  • Figure 90 Europe Women's Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 91 Europe Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 92 Europe Women's Health Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 93 Europe Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 94 Europe Women's Health Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 95 Europe Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
  • Figure 96 Europe Women's Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
  • Figure 97 Europe Women's Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
  • Figure 98 Europe Women's Health Market Share Forecast by Drugs, 2024 & 2034 (%)
  • Figure 99 Europe Women's Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 100 Europe Women's Health Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 101 Germany Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 102 France Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 103 UK Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 104 Italy Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 105 Spain Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 106 Russia Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 107 Poland Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 108 Belgium Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 109 Rest of Europe Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 110 Asia Pacific Women's Health Market Attractiveness Index
  • Figure 111 Asia Pacific Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • Figure 112 Asia Pacific Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 113 Asia Pacific Women's Health Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 114 Asia Pacific Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 115 Asia Pacific Women's Health Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 116 Asia Pacific Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
  • Figure 117 Asia Pacific Women's Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
  • Figure 118 Asia Pacific Women's Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
  • Figure 119 Asia Pacific Women's Health Market Share Forecast by Drugs, 2024 & 2034 (%)
  • Figure 120 Asia Pacific Women's Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 121 Asia Pacific Women's Health Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 122 Japan Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 123 China Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 124 India Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 125 Australia Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 126 South Korea Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 127 Singapore Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 128 Taiwan Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 129 Rest of Asia Pacific Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 130 Latin America Women's Health Market Attractiveness Index
  • Figure 131 Latin America Women's Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 132 Latin America Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 133 Latin America Women's Health Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 134 Latin America Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 135 Latin America Women's Health Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 136 Latin America Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
  • Figure 137 Latin America Women's Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
  • Figure 138 Latin America Women's Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
  • Figure 139 Latin America Women's Health Market Share Forecast by Drugs, 2024 & 2034 (%)
  • Figure 140 Latin America Women's Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 141 Latin America Women's Health Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 142 Brazil Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 143 Mexico Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 144 Argentina Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 145 Colombia Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 146 Rest of Latin America Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 147 MEA Women's Health Market Attractiveness Index
  • Figure 148 MEA Women's Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 149 MEA Women's Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 150 MEA Women's Health Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 151 MEA Women's Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 152 MEA Women's Health Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 153 MEA Women's Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
  • Figure 154 MEA Women's Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
  • Figure 155 MEA Women's Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
  • Figure 156 MEA Women's Health Market Share Forecast by Drugs, 2024 & 2034 (%)
  • Figure 157 MEA Women's Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 158 MEA Women's Health Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 159 GCC Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 160 South Africa Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 161 Rest of MEA Women's Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 162 Women Health Market Company Share, 2022
  • Figure 163 Abbott Laboratories: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 164 Abbott Laboratories: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 165 Bayer AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 166 Bayer AG : R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 167 Bayer AG: Regional Market Shares, 2022
  • Figure 168 Cardinal Health: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 169 Cardinal Health: Regional Market Shares, 2023
  • Figure 170 Cooper Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 171 Cooper Surgical, Inc.: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 172 Cooper Surgical, Inc.: Regional Market Shares, 2023
  • Figure 173 L. Hoffman-La Roche Ltd.: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 174 L. Hoffman-La Roche Ltd.: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 175 General Electric Healthcare: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 176 General Electric Healthcare: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 177 General Electric Healthcare: Regional Market Shares, 2022
  • Figure 178 Hologic Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 179 Hologic Inc: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 180 Hologic Inc: Regional Market Shares, 2022
  • Figure 181 Koninklijke Philips N.V: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 182 Koninklijke Philips N.V: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 183 Prestige Consumer Healthcare Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 184 Siemens AG: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 185 Siemens AG: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 186 Siemens AG: Regional Market Shares, 2023
目次
Product Code: PHA1318

The global Women's Health market is estimated to grow at a CAGR of 4.6% by 2034

The Women's Health Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing awareness about women's health issues

The women's health market is experiencing significant growth due to increasing awareness about women's health issues. This growth is driven by various factors such as rising healthcare expenditures, advancements in medical technology, and a greater focus on preventive care. There is a growing demand for products and services addressing women's unique health needs, including reproductive health, maternal health, breast health, menopause management, and sexual health. Additionally, initiatives promoting women's health education and advocacy have contributed to a greater understanding of gender-specific health concerns and the importance of early detection and treatment. The women's health market is expected to continue expanding, offering opportunities for innovation and improved healthcare outcomes for women worldwide.

Technological advancements in patient care

Technological advancements are rapidly reshaping the landscape of the women's health market, ushering in a new era of innovation and improved patient care. From sophisticated diagnostic tools to cutting-edge treatment modalities, these advancements are revolutionizing the way women's health conditions are diagnosed, managed, and treated. Advanced imaging techniques, such as 3D mammography and MRI, offer greater accuracy in detecting breast cancer at its earliest stages, improving survival rates and reducing the need for invasive procedures. Minimally invasive surgical techniques, including laparoscopy and robotic-assisted surgery, are providing safer and more effective options for addressing gynaecological conditions like endometriosis and fibroids. Moreover, digital health solutions such as mobile apps, wearable devices, and telemedicine platforms are empowering women to take charge of their health by providing convenient access to information, monitoring tools, and virtual consultations with healthcare providers. These technological innovations hold immense promise for enhancing women's health outcomes, driving market growth, and advancing the overall quality of care in the field of women's health.

What Questions Should You Ask before Buying a Market Research Report?

How is the Women's Health Market evolving?

What is driving and restraining the Women's Health Market?

How will each Women's Health submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Women's Health submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Women's Health Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Women's Health projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Women's Health projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Women's Health Market?

Where is the Women's Health Market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Women's Health Market today, and over the next 10 years:

Our 351-page report provides 125 tables and 186 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Women's Health Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Women's Health prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

By Application

Contraceptives

Postmenopausal osteoporosis

Hormonal infertility

Menopause

Polycystic Ovary Syndrome

Endometriosis and Uterine Fibroids

Others

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Drugs

Prolia

Xgeva

Mirena

Nexplanon

Forteo

Nuvaring

Premarin

Lupron

Lo Loestrin

Orilissa/Oriahnn

Others

By Type

Generics

Branded

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Women's Health Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Abbott

Bayer AG

Caldera Medical

Cardinal Health

Carestream

Cooper Surgical Inc.

L. Hoffman-La Roche Ltd.

GE Healthcare

Hologic

Koninklijke Philips N.V

MedGyn Products

Medline Industries, Inc.

Prestige Consumer Healthcare, Inc.

Siemens AG

Overall world revenue for Women's Health Market, 2024 to 2034 in terms of value the market will surpass US$ 61.0 billion in 2034, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Women's Health Market, 2024 to 2034 report help you?

In summary, our 350+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Women's Health Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 16 key national markets - See forecasts for the Women's Health Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Women's Health Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Women's Health Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Women's Health Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Heightened Attention Towards Emerging Economies
      • 3.2.1.2 Escalated Innovation Targeting New Therapeutic Solutions
      • 3.2.1.3 Expanded Investments in Technology to Enhance Patient Satisfaction
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Elevated Pricing Poses a Constraint on Market Expansion
      • 3.2.2.2 Increased Collaboration for the Development of Advanced Healthcare Infrastructure
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Expansion of Preventative Care Services Tailored to Women's Unique Health Needs.
      • 3.2.3.2 Improving Digital Health Platforms to Enhance the Access to Healthcare Services for Women, Particularly in Underserved Areas.
      • 3.2.3.3 Technological Advancements in Reproductive Health Services, Including Family Planning, Fertility Management, and Maternal Care
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Women's Health Market Analysis by Application

  • 4.1 Key Findings
  • 4.2 Application Segment: Market Attractiveness Index
  • 4.3 Women's Health Market Size Estimation and Forecast by Application
  • 4.4 Contraceptives
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Postmenopausal Osteoporosis
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Hormonal Infertility
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Menopause
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Polycystic Ovary Syndrome
    • 4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Endometriosis and Uterine Fibroids
    • 4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Others
    • 4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)

5 Women's Health Market Analysis by Distribution Channel

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Women's Health Market Size Estimation and Forecast by Distribution Channel
  • 5.4 Hospital Pharmacies
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Retail Pharmacies
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Online Pharmacies
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Women's Health Market Analysis by Drugs

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
  • 6.3 Women's Health Market Size Estimation and Forecast by Drugs
  • 6.4 Xgeva
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Prolia
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Mirena
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Nexplanon
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)
  • 6.8 Forteo
    • 6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.8.2 Market Share by Region, 2024 & 2034 (%)
  • 6.9 Nuvaring
    • 6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.9.2 Market Share by Region, 2024 & 2034 (%)
  • 6.10 Premarin
    • 6.10.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.10.2 Market Share by Region, 2024 & 2034 (%)
  • 6.11 Lupron
    • 6.11.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.11.2 Market Share by Region, 2024 & 2034 (%)
  • 6.12 Lo Loestrin
    • 6.12.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.12.2 Market Share by Region, 2024 & 2034 (%)
  • 6.13 Orilissa/Oriahnn
    • 6.13.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.13.2 Market Share by Region, 2024 & 2034 (%)
  • 6.14 Others
    • 6.14.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.14.2 Market Share by Region, 2024 & 2034 (%)

7 Women's Health Market Analysis by Type

  • 7.1 Key Findings
  • 7.2 Application Segment: Market Attractiveness Index
  • 7.3 Women's Health Market Size Estimation and Forecast by Type
  • 7.4 Generic
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Branded
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)

8 Women's Health Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Women's Health Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Women's Health Market Attractiveness Index
  • 9.3 North America Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 North America Women's Health Market Size Estimation and Forecast by Country
  • 9.5 North America Women's Health Market Size Estimation and Forecast by Application
  • 9.6 North America Women's Health Market Size Estimation and Forecast by Distribution Channel
  • 9.7 North America Women's Health Market Size Estimation and Forecast by Drugs
  • 9.8 North America Women's Health Market Size Estimation and Forecast by Type
  • 9.9 U.S. Women's Health Market Analysis
  • 9.10 Canada Women's Health Market Analysis

10 Europe Women's Health Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Women's Health Market Attractiveness Index
  • 10.3 Europe Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Europe Women's Health Market Size Estimation and Forecast by Country
  • 10.5 Europe Women's Health Market Size Estimation and Forecast by Application
  • 10.6 Europe Women's Health Market Size Estimation and Forecast by Distribution Channel
  • 10.7 Europe Women's Health Market Size Estimation and Forecast by Drugs
  • 10.8 Europe Women's Health Market Size Estimation and Forecast by Type
  • 10.9 Germany Women's Health Market Analysis
  • 10.10 France Women's Health Market Analysis
  • 10.11 UK Women's Health Market Analysis
  • 10.12 Italy Women's Health Market Analysis
  • 10.13 Spain Women's Health Market Analysis
  • 10.14 Russia Women's Health Market Analysis
  • 10.15 Poland Women's Health Market Analysis
  • 10.16 Belgium Women's Health Market Analysis
  • 10.17 Rest of Europe Women's Health Market Analysis

11 Asia Pacific Women's Health Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Women's Health Market Attractiveness Index
  • 11.3 Asia Pacific Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 Asia Pacific Women's Health Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Women's Health Market Size Estimation and Forecast by Application
  • 11.6 Asia Pacific Women's Health Market Size Estimation and Forecast by Distribution Channel
  • 11.7 Asia Pacific Women's Health Market Size Estimation and Forecast by Drugs
  • 11.8 Asia Pacific Women's Health Market Size Estimation and Forecast by Type
  • 11.9 Japan Women's Health Market Analysis
  • 11.10 China Women's Health Market Analysis
  • 11.11 India Women's Health Market Analysis
  • 11.12 Australia Women's Health Market Analysis
  • 11.13 South Korea Women's Health Market Analysis
  • 11.14 Singapore Women's Health Market Analysis
  • 11.15 Taiwan Women's Health Market Analysis
  • 11.16 Rest of Asia Pacific Women's Health Market Analysis

12 Latin America Women's Health Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Women's Health Market Attractiveness Index
  • 12.3 Latin America Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 12.4 Latin America Women's Health Market Size Estimation and Forecast by Country
  • 12.5 Latin America Women's Health Market Size Estimation and Forecast by Application
  • 12.6 Latin America Women's Health Market Size Estimation and Forecast by Distribution Channel
  • 12.7 Latin America Women's Health Market Size Estimation and Forecast by Drugs
  • 12.8 Latin America Women's Health Market Size Estimation and Forecast by Type
  • 12.9 Brazil Women's Health Market Analysis
  • 12.10 Mexico Women's Health Market Analysis
  • 12.11 Argentina Women's Health Market Analysis
  • 12.12 Colombia Women's Health Market Analysis
  • 12.13 Rest of Latin America Women's Health Market Analysis

13 MEA Women's Health Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Women's Health Market Attractiveness Index
  • 13.3 MEA Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 13.4 MEA Women's Health Market Size Estimation and Forecast by Country
  • 13.5 MEA Women's Health Market Size Estimation and Forecast by Application
  • 13.6 MEA Women's Health Market Size Estimation and Forecast by Distribution Channel
  • 13.7 MEA Women's Health Market Size Estimation and Forecast by Drugs
  • 13.8 MEA Women's Health Market Size Estimation and Forecast by Type
  • 13.9 GCC Women's Health Market Analysis
  • 13.10 South Africa Women's Health Market Analysis
  • 13.11 Rest of MEA Women's Health Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2022
  • 14.2 Summary of all Strategic Outlook
  • 14.3 Abbott Laboratories
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2017-2022
      • 14.3.3.2 R&D, 2017-2022
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Bayer AG
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2017-2022
      • 14.4.3.2 R&D, 2017-2022
      • 14.4.3.3 Regional Market Shares, 2022
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 Caldera Medical Inc.
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Product Benchmarking
    • 14.5.4 Strategic Outlook
  • 14.6 Cardinal Health
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2017-2023
      • 14.6.3.2 Regional Market Shares, 2023
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Carestream Health
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Product Benchmarking
    • 14.7.4 Strategic Outlook
  • 14.8 Cooper Surgical Inc.
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2017-2023
      • 14.8.3.2 R&D, 2017-2023
      • 14.8.3.3 Regional Market Shares, 2023
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 L. Hoffman-La Roche Ltd.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2017-2023
      • 14.9.3.2 R&D, 2017-2023
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 General Electric Healthcare
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2017-2022
      • 14.10.3.2 R&D, 2017-2022
      • 14.10.3.3 Regional Market Shares, 2022
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Hologic Inc.
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2017-2023
      • 14.11.3.2 R&D, 2017-2023
      • 14.11.3.3 Regional Market Shares, 2022
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 koninklijke philips n.v
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2017-2022
      • 14.12.3.2 R&D, 2017-2022
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 MedGyn Products Inc.
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Product Benchmarking
  • 14.14 Medline Industries, Inc.
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Product Benchmarking
  • 14.15 Prestige Consumer Healthcare Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2017-2022
    • 14.15.4 Product Benchmarking
  • 14.16 Siemens AG
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
      • 14.16.3.1 Net Revenue, 2017-2023
      • 14.16.3.2 R&D, 2017-2023
      • 14.16.3.3 Regional Market Shares, 2023
    • 14.16.4 Product Benchmarking
    • 14.16.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players